Carvacrol suppresses the expression of inflammatory marker genes in D-galactosamine-hepatotoxic rats

Asian Pacific Journal of Tropical Medicine

Volumn 6, Issue 3, 2013, Pages 205-211

  Aristatile, Balakrishnan ^a,b   Al Assaf, Abdullah H ^b   Pugalendi, Kodukkur Viswanathan ^c  

^a BHARATHIAR UNIVERSITY   (India)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c ANNAMALAI UNIVERSITY   (India)

Author keywords

Anti inflammatory; Carvacrol; D galactosamine; Hepatotoxicity

Indexed keywords

CARVACROL; CYCLOOXYGENASE 2; GALACTOSAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; SILYMARIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; INFLAMMATION; LIVER TOXICITY; MALE; MARKER GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; GALACTOSAMINE; INTERLEUKIN-6; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MONOTERPENES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SILYMARIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873114428     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(13)60024-3     Document Type: Article

References (51)

1. Russell A, Boyd J, Nakada T, Thair S, Walley KR Molecular mechanisms of sepsis. Contrib Microbiol 2011, 17:48-85.
2. Clavien PA, Trotter JF Fulminant hepatic failure, in medical care of the liver transplant patient 2012, Wiley-Blackwell, Oxford. 4th edition, 10.1002/9781444398441.ch16.
3. Das J, Ghosh J, Roy A, Sil PC Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFκB pathways. Toxicol Appl Pharmacol 2012, 260:35-47.
4. Dhanabal SP, Rahul J, Priyanka DL, Muruganantham N, Raghu PS Hepatoprotective activity of Santolina chamaecyparissus Linn against D-Galactosamine induced hepatotoxicity in rats. Phcog Commn 2012, 2:67-70.
5. Lee WC, Kim JK, Kang JW, Oh WY, Jung JY, Kim YS, et al. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice. Food Chem Toxicol 2010, 48:222-228.
6. Liong EC, Xiao J, Lau TY, Nanji AA, Tipoe GL Cyclooxygenase inhibitors protect D-galactosamine/lipopolysaccharide induced acute hepatic injury in experimental mice model. Food Chem Toxicol 2012, 50:861-866.
7. Jang CH, Choi JH, Byun MS, Jue DM Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes. Rheumatology (Oxford) 2006, 45:703-710.
8. Penz-österreicher M, österreicher CH, Trauner M Fibrosis in autoimmune and cholestatic liver disease. Best Pract Res Clin Gastroenterol 2011, 25:245-258.
9. Kshirsagar A, Vetal Y, Ashok P, Bhosle P, Ingawale D Drug induced hepatotoxicity: A comprehensive review. Internet J Pharmacol 2009, 7:1.
10. Lozano JM, Padillo J, Montero JL, Peña J, De la Mata M, Muntane J Immunomodulatory activity of TNF-alpha during acute liver injury induced by D-galactosamine and its protection by PGE1 in rats. Int Immunopharmacol 2003, 3:197-207.
11. Goral V, Atayan Y, Kaplan A The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α?. Hepatogastroenterology 2011, 58:943-948.
12. Yang X, Sun Q, Asim MB, Jiang X, Zhong B, Shahzad M, et al. Nitric oxide in both bronchoalveolar lavage fluid and serum is associated with pathogenesis and severity of antigen-induced pulmonary inflammation in rats. J Asthma 2010, 47:135-144.
13. Kleinert H, Pautz A, Linker K, Schwarz PM Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 2004, 500:255-266.
14. Kanwar JR, Kanwar RK, Burrow H, Baratchi S Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr Med Chem 2009, 16:2373-2394.
15. Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 2007, 46:108-125.
16. Hinz B, Brune K Cyclooxygenase 2-10 years later. J Pharmacol Exp Ther 2002, 300:367-375.
17. Sonoda R, Naomoto Y, Shirakawa Y, Fujiwara Y, Yamatsuji T, Noma K, et al. Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma. Histopathology 2010, 57:90-100.
18. Scheibel M, Klein B, Merkle H, Schulz M, Fritsch R, Greten FR, et al. IkappaBbeta is an essential co-activator for LPS-induced IL-1beta transcription in vivo. J Exp Med 2010, 207:2621-2630.
19. Dong J, Jimi E, Zeiss C, Hayden MS, Ghosh S Constitutively active NF-kappaB triggers systemic TNF alpha-dependent inflammation and localized TNF alpha-independent inflammatory disease. Genes Dev 2010, 24:1709-1717.
20. Park MH, Song HS, Kim KH, Son DJ, Lee SH, Yoon DY Cobrotoxin inhibits NF-κB activation and target gene expression through reaction with NF-κB signal molecules. Biochemistry 2005, 44:8326-8336.
21. Mi Jeong S, Davaatseren M, Kim W, Sung Kwang P, Kim SH, Haeng Jeon H, et al. Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-kappaB activation in RAW 264.7 cells. Int Immunopharmacol 2009, 9:319-323.
22. Cho EJ, An HJ, Shin JS, Choi HE, Ko J, Cho YW, et al. Roxatidine suppresses inflammatory responses via inhibition of NF-κB and p38 MAPK activation in LPS-induced RAW 264.7 macrophages. J Cell Biochem 2011, 112:3648-3659.
23. Sigala I, Zacharatos P, Toumpanakis D, Michailidou T, Noussia O, Theocharis S, et al. MAPKs and NF-κB differentially regulate cytokine expression in the diaphragm in response to resistive breathing: the role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 2011, 300:R1152-R1162.
24. Ajizian SJ, English BK, Meals EA Specific inhibitors of p38 and extracellular signalregulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 1999, 179:939-944.
25. De Vincenzi M, Stammati A, De Vincenzi A, Silano M Constituents of aromatic plants: carvacrol. Fitoterapia 2004, 75:801-804.
26. Landa P, Kokoska L, Pribylova M, Vanek T, Marsik P In vitro anti-inflammatory activity of carvacrol: inhibitory effect on COX-2 catalyzed prostaglandin E(2) biosynthesis. Arch Pharm Res 2009, 32:75-78.
27. Chen F, Shi Z, Neoh KG, Kang ET Antioxidant and antibacterial activities of eugenol and carvacrol-grafted chitosan nanoparticles. Biotechnol Bioeng 2009, 104:30-39.
28. Yin QH, Yan FX, Zu XY, Wu YH, Wu XP, Liao MC, et al. Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology 2012, 64:43-51.
29. Jaafari A, Tilaoui M, Ait Mouse H, Ait Mbark L, Aboufatima R, Chait A, et al. Comparative study of the antitumor effect of natural monoterpenes: relationship to cell cycle analysis. 2012. [Online] http://dx.doi.org/10.1590/S0102-695X2012005000021.
30. Keppler D, Decker K Studies on the mechanism of galactosamine hepatitis: accumulation of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur J Biochem 1969, 10:219-225.
31. Bradley JR TNF-mediated inflammatory disease. J Pathol 2008, 214:149-160.
32. Oztay F, Gezginci-Oktayoglu S, Bayrak BB, Yanardag R, Bolkent S Cathepsin B inhibition improves lung injury associated to D-galactosamine/tumor necrosis factor-alpha-induced liver injury in mice. Mol Cell Biochem 2010, 333:65-72.
33. Lee WC, Kim JK, Kang JW, Oh WY, Jung JY, Kim YS, et al. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice. Food Chem Toxicol 2010, 48:222-228.
34. Chosay JG, Essani NA, Dunn CJ, Jaeschke H Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol 1997, 272:G1195-G1200.
35. Jaeschke H Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 2006, 290:G1083-G1088.
36. Buras JA, Holzmann B, Sitkovsky M Animal models of sepsis: setting the stage. Nat Rev Drug Discov 2005, 4:854-865.
37. Adamzik M, Eggmann M, Frey UH, Görlinger K, Bröcker-Preuss M, Marggraf G, et al. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit Care 2010, 14(5):R178.
38. Libert C, Takahashi N, Cauwels A, Brouckaert P, Bluethmann H, Fiers W Response of interleukin 6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur J Immunol 1994, 24:2237-2242.
39. Chen JH, Tipoe GL, Liong EC, So HS, Leung KM, Tom WM, et al. Green tea polyphenols prevent toxininduced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am J Clin Nutr 2004, 80:742-751.
40. Tipoe GL, Leung TM, Liong E, So H, Leung KM, Lau TY, et al. Inhibitors of inducible nitric oxide (NO) synthase are more effective than an NO donor in reducing carbon-tetrachloride induced acute liver injury. Histol Histopathol 2006, 21:1157-1165.
41. Bultinck J, Sips P, Vakaet L, Brouckaert P, Cauwels A Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock. FASEB J 2006, 20:2363-2365.
42. Serhan CN, Oliw E Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 2001, 107:1481-1489.
43. Ben Abdennebi H, Zaoualí MA, Alfany-Fernandez I, Tabka D, Roselló-Catafau J How to protect liver graft with nitric oxide. World J Gastroenterol 2011, 17:2879-2889.
44. Hu KQ Cyclooxygenase 2 (COX-2)-prostanoid pathway and liver diseases. Prostaglandins Leukot. Essent Fatty Acids 2003, 69:329-337.
45. Aristatile B, Al-Numair KS, Veeramani C, Pugalendi KV Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine induced-hepatotoxicity in rats. Fundamen Clin Pharmacol 2009, 23:757-765.
46. Dambach DM, Durham SK, Laskinc JD, Laskin DL Distinct roles of NF-jB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol Appl Pharmacol 2006, 211:157-165.
47. Kang G, Choi YH, Choi W, Lee J, Kim G Inhibition of lipopolysaccharide-induced iNOS, COX-2, and TNF-α expression by aqueous extract of Orixa japonica in RAW 264.7 cells via suppression of NF-κB activity. Trop J Pharm Res l 2011, 10:161-168.
48. Jimenez-Lopez JM, Wu D, Cederbaum AI Synergistic toxicity induced by prolonged glutathione depletion and inhibition of nuclear factor-kappaB signaling in liver cells. Toxicol In Vitro 2008, 22:106-115.
49. Joh EH, Kim DH Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways. Br J Pharmacol 2011, 162:1731-1742.
50. Wakamatsu K, Nanki T, Miyasaka N, Umezawa K, Kubota T Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells. Arthritis Res Ther 2005, 7:R1348-R1359.
51. Culver C, Sundqvist A, Mudie S, Melvin A, Xirodimas D, Rocha S Mechanism of hypoxia-induced NF-kappaB. Mol Cell Biol 2010, 30:4901-4921.